Last reviewed · How we verify

NCT06069128: paralysis

Evaluate the Usability of the Neuro-trigger Artificial Eye Blinking Stimulation Device in Patients With Paralysis of the Facial Nerve.

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Neurotrigger Basic. eye blinking stimulator in Paralysis in 11 participants. Completed in 5 September 2024.

Timeline
1 October 2023
Primary endpoint
1 August 2024
5 September 2024

Quick facts

Lead sponsorNeurotrigger Ltd
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment11
Start date1 October 2023
Primary completion1 August 2024
Estimated completion5 September 2024
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Neurotrigger Ltd

Who can join

Adults 18 to 120, any sex, with Paralysis or Paralysis; Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center, open-label clinical study. Up to 11 subjects will be enrolled to use the Neuro-trigger device for blinking stimulation for a duration of 14 days.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Paralysis

Currently open trials in the same condition.

Other Neurotrigger Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06069128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing